Capacity Building Grants for FSR Global Sarcoidosis Clinic Alliance (FSR-GSCA)  (1)
Foundation for Sarcoidosis Research Announces 3 New Members to the 40 Member FSR Global Sarcoidosis Clinic Alliance through its FSR-GSCA Capacity Building Grants
November 01, 2023 11:26 ET | Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research announces three clinics that have been selected as members of FSR Global Sarcoidosis Clinic Alliance
NOVARTIS logo.jpg
FDA approves Novartis Cosentyx® as the first new biologic treatment option for hidradenitis suppurativa patients in nearly a decade
October 31, 2023 16:50 ET | Novartis Pharma AG
FDA approval based on robust Phase III data in which Cosentyx® (secukinumab) showed rapid relief from symptoms of hidradenitis suppurativa (HS) as early as Week 21 As the only IL-17A inhibitor...
patient summit 2023 invite
Foundation for Sarcoidosis Research announces largest Global Sarcoidosis Virtual Summit – Find Your Community, Find Your Life
September 26, 2023 09:15 ET | Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research to Host Largest Virtual Sarcoidosis Educational Event of the Year
NOVARTIS logo.jpg
Novartis remibrutinib Phase III trials met their primary endpoints and showed rapid symptom control in chronic spontaneous urticaria
August 09, 2023 01:15 ET | Novartis Pharma AG
Ad hoc announcement pursuant to Art. 53 LR The Phase III REMIX-1 and REMIX-2 studies met all primary and secondary endpoints, showing rapid, clinically meaningful improvements across...
Global Pet Insurance Market Foreseen to Garner $28,377.8 Million, Growing at 15.3% CAGR in the 2021–2028 Timeframe [235-Pages] | Announced by Research Dive
April 20, 2023 10:25 ET | Research Dive
New York, USA, April 20, 2023 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global pet insurance market. According to the report, the global market is projected to surpass...
Featured Image for Lifestyle Healing Institute
With Expanded Outdoor Features, Lifestyle Healing Institute Integrates Traditional and Holistic Medicine
August 29, 2022 08:04 ET | Lifestyle Healing Institute
NAPLES, Fla., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Lifestyle Healing Institute, a center for complementary and alternative medicine, treats illnesses with data-driven approaches delivered by a medical...
Growth: Significant Rise in the Adoption of Pets Across the Globe to Propel the Growth of the Global Pet Insurance Market [235-Pages] | Reveals by Research Dive
March 21, 2022 09:05 ET | Research Dive
New York, USA, March 21, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global pet insurance market is expected to generate a revenue of $28,377.8 million by 2028,...
The ASA and the NCCAOM Support the Acupuncture for Our Seniors Act WASHINGTON, July 30, 2021 (GLOBE NEWSWIRE) -- The American Society of Acupuncturists (ASA) and the National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM) are pleased to...
NOVARTIS logo.jpg
Novartis presents positive Phase III results from JUNIPERA study supporting Cosentyx® as a potential treatment in a JIA population at EULAR 2021
June 02, 2021 01:15 ET | Novartis Pharma AG
Phase III JUNIPERA study met its primary endpoint, with Cosentyx® (secukinumab) showing significantly longer time to flare (longer time to worsening of symptoms1) vs. placebo (P<.001) in pediatric...
NOVARTIS logo.jpg
Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis
June 01, 2021 16:30 ET | Novartis Pharma AG
Approval for moderate to severe pediatric patients six years and older is based on pivotal trial data showing Cosentyx demonstrated superior improvements of skin symptoms compared to placebo1 The...